Ads by Google

Mesothelioma Cancer

Update: Further Progress to Helping Patients with Interstitial Lung Disease

Breathing asbestos and dangers

Interstitial Lung Disease (ILD) has many lung disorders that fall under that term. One of them Idiopathic Pulmonary Fibrosis (IPF), is the most common of these disorders. Asbestosis is diffuse pulmonary fibrosis resulting in a slowly progressing disease that can take from 15 to 40 years after exposure to be encountered physical symptoms. And while in most developing countries it has been banned, the exposure-related diagnoses are still being cared for.

Mesothelioma Cancer Survivor Offers Hope After 6 Years

Let's start with Mesothelioma hope. A new drug mixture of tremelimumab and Imfinzi (durvalumab) show encouraging results in the first phase II mesothelioma clinical trial examining this combination. The study, which included 40 mesothelioma patients in Italy, was published in the June 2018 edition of The Lancet Respiratory Medicine.

Pages